AT-004
Asset
Targets the non-neuronal cholinergic system to promote anti-inflammatory and repair activities in skin.
- Stage
- Phase 2
- Modality
- Not known
- Target
- Not known
- 3
- Indications
- 0
- Trials
- 1
- Developer
Indications
3Acne vulgaris
Phase 2, arctictherapeutics.com, 10 Oct 2026
Atopic dermatitis
Phase 2, arctictherapeutics.com, 10 Oct 2026
Psoriasis
Phase 2, arctictherapeutics.com, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.